Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS1GHT: Colchicine for Insulin Sensitivity in Type 1 Diabetes
NCT07247734Phase 2Recruiting
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in type 1 diabetes mellitus (T1D). Started Dec 2025; status: recruiting.
02
Drugs
colchicine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07247734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07247734.